A multivariate analysis showed that CaSR was of independent prognostic significance for both overall survival and cause-specific survival of breast cancer patients; the patients with lower expression of CaSR were also significantly associated with distant metastasis-free survival. This evidence concerns the gene CASR and breast cancer.